The total return over the past 12 months is -69.76% vs. +16.94% for the S&P 500. So far it's up -75.10% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (69.76%) | (23.22%) | (37.41%) | N/A | N/A | N/A |
| Total Return CAGR | (69.76%) | (23.22%) | (37.41%) | N/A | N/A | N/A |
| Revenue CAGR | +6.34% | +0.61% | +1.05% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | (5.54%) | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | +23.86% | (7.91%) | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Organogenesis Holdings Inc. (ORGO)
| Year | Start price | End price | ORGO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.18 | $1.29 | (75.10%) | +14.51% | (89.61%) |
| 2025 | $3.20 | $5.18 | +61.87% | +17.72% | +44.15% |
| 2024 | $4.09 | $3.20 | (21.76%) | +24.89% | (46.65%) |
| 2023 | $2.69 | $4.09 | +52.04% | +26.19% | +25.85% |
| 2022 | $9.24 | $2.69 | (70.89%) | (18.17%) | (52.72%) |
| 2021 | $7.53 | $9.24 | +22.71% | +28.74% | (6.03%) |
| 2020 | $4.81 | $7.53 | +56.55% | +18.37% | +38.18% |
| 2019 | $10.15 | $4.81 | (52.61%) | +31.22% | (83.83%) |
| 2018 | $9.92 | $10.15 | +2.32% | (4.56%) | +6.88% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
